GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today the appointment of Bill Shopoff as vice president of U.S. sales for large joints. The appointment is effective today.
A 30-year veteran of the orthopaedic industry, Shopoff has provided global sales and business leadership for Smith & Nephew since 1984, most recently serving as president of the Trauma and Extremities franchise.
He replaces Bob Purcell who will retire after more than 40 years in orthopaedics and healthcare capital equipment sales. During Purcell’s six years as Exactech’s vice president of U.S. Sales, he strengthened the domestic sales team and led the organization to a compound annual growth rate of 10 percent.
“Bill Shopoff’s extensive experience in orthopaedic sales management is complemented by strong business leadership. These skills make him uniquely suited to build on the strong foundation that Bob Purcell has established within our domestic sales organization,” said Exactech President David Petty. “We have great appreciation for Bob Purcell’s contributions and plan to continue to leverage his expertise in strategic accounts contracting by engaging him as a consultant.”
Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at http://www.exac.com and http://www.hawkassociates.com.
This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.